March 2023 in numbers
NHS community prescribing in England (Prescription Cost Analysis).
104,455,850items
Dispensed in March 2023
NHSBSA Prescription Cost Analysis
£956,532,879
Net ingredient cost, March 2023
NHSBSA PCA
Most-dispensed medicines
Download full month (CSV)| Medicine | Items | Net ingredient cost |
|---|---|---|
| Atorvastatin | 5,431,810 | £6,692,780 |
| Amlodipine | 3,214,432 | £3,337,605 |
| Omeprazole | 3,145,390 | £14,690,177 |
| Lansoprazole | 2,971,023 | £4,159,964 |
| Levothyroxine sodium | 2,959,281 | £4,680,318 |
| Ramipril | 2,873,753 | £4,113,257 |
| Bisoprolol fumarate | 2,472,496 | £2,656,852 |
| Colecalciferol | 2,327,665 | £9,459,812 |
| Metformin hydrochloride | 2,180,606 | £7,405,087 |
| Sertraline hydrochloride | 2,012,504 | £3,437,161 |
| Salbutamol | 1,852,803 | £5,631,629 |
| Aspirin | 1,776,648 | £1,471,548 |
Biggest risers
Largest month-on-month rise in items (medicines above 10,000 items).
| Medicine | Items | Change |
|---|---|---|
| Oral rehydration salts | 14,857 | +30.3% |
| Progesterone | 176,216 | +27.0% |
| Sodium cromoglicate | 50,689 | +26.7% |
| Olopatadine | 19,446 | +26.1% |
| Chlorhexidine gluconate | 13,157 | +25.7% |
| Orlistat | 35,160 | +24.5% |
| Edoxaban | 344,730 | +23.9% |
| Skin Protectors | 25,299 | +23.7% |
Biggest fallers
Largest month-on-month fall in items.
| Medicine | Items | Change |
|---|---|---|
| Influenza | 280,812 | −33.8% |
| Capsaicin | 10,367 | −11.7% |
| Other individually formulated bought in preparations | 27,203 | −11.0% |
| Heparinoid | 11,114 | −3.8% |
| Terbinafine hydrochloride | 14,891 | +0.3% |
| Typhoid | 37,370 | +0.6% |
| Diphtheria | 18,055 | +2.4% |
| Amoxicillin | 1,001,251 | +4.6% |